Drug-Induced Photosensitivity Differential Diagnoses
- Author: Alexandra Y Zhang, MD; Chief Editor: Dirk M Elston, MD more...
Fox GN, Harrell CC, Mehregan DR. Extensive lichenoid drug eruption due to glyburide: a case report and review of the literature. Cutis. Jul 2005;76(1):41-5. [Medline].
Onoue S, Seto Y, Gandy G, Yamada S. Drug-induced phototoxicity; an early in vitro identification of phototoxic potential of new drug entities in drug discovery and development. Curr Drug Saf. May 2009;4(2):123-36. [Medline].
Günes AT, Fetil E, Ilknur T, Birgin B, Ozkan S. Naproxen-induced lichen planus: report of 55 cases. Int J Dermatol. Jun 2006;45(6):709-12. [Medline].
Yazici AC, Baz K, Ikizoglu G, Kokturk A, Uzumlu H, Tataroglu C. Celecoxib-induced photoallergic drug eruption. Int J Dermatol. Jun 2004;43(6):459-61. [Medline].
Suchak R, Benson K, Swale V. Statin-induced Ro/SSa-positive subacute cutaneous lupus erythematosus. Clin Exp Dermatol. Sep 2007;32(5):589-91. [Medline].
Kong HH, Fine HA, Stern JB, Turner ML. Cutaneous pigmentation after photosensitivity induced by vandetanib therapy. Arch Dermatol. Aug 2009;145(8):923-5. [Medline].
Gupta AK, Ryder JE. Photodynamic therapy and topical aminolevulinic acid: an overview. Am J Clin Dermatol. 2003;4(10):699-708. [Medline].
Houle JM, Strong HA. Duration of skin photosensitivity and incidence of photosensitivity reactions after administration of verteporfin. Retina. Dec 2002;22(6):691-7. [Medline].
Moriwaki SI, Misawa J, Yoshinari Y, Yamada I, Takigawa M, Tokura Y. Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin). Photodermatol Photoimmunol Photomed. Oct 2001;17(5):241-3. [Medline].
Eberlein-Konig B, Bindl A, Przybilla B. Phototoxic properties of neuroleptic drugs. Dermatology. 1997;194(2):131-5. [Medline].
Llambrich A, Lecha M. Photoinduced lichenoid reaction by thioridazine. Photodermatol Photoimmunol Photomed. Apr 2004;20(2):108-9. [Medline].
Dolan CK, Hall MA, Blazes DL, Norwood CW. Pseudoporphyria as a result of voriconazole use: a case report. Int J Dermatol. Oct 2004;43(10):768-71. [Medline].
Patel AR, Turner ML, Baird K, et al. Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. Mar 2009;15(3):370-6. [Medline].
Racette AJ, Roenigk HH Jr, Hansen R, Mendelson D, Park A. Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl. J Am Acad Dermatol. May 2005;52(5 Suppl 1):S81-5. [Medline].
Rubenstein M, Levy ML, Metry D. Voriconazole-induced retinoid-like photosensitivity in children. Pediatr Dermatol. Nov-Dec 2004;21(6):675-8. [Medline].
Cohen PR. Photodistributed erythema multiforme: paclitaxel-related, photosensitive conditions in patients with cancer. J Drugs Dermatol. Jan 2009;8(1):61-4. [Medline].
Morison WL. Solar urticaria due to progesterone compounds in oral contraceptives. Photodermatol Photoimmunol Photomed. Jun 2003;19(3):155-6. [Medline].
Silver EA, Silver AH, Silver DS, McCalmont TH. Pseudoporphyria induced by oral contraceptive pills. Arch Dermatol. Feb 2003;139(2):227-8. [Medline].
Gonzalez E, Gonzalez S. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol. Dec 1996;35(6):871-85; quiz 886-7. [Medline].
Ellgehausen P, Elsner P, Burg G. Drug-induced lichen planus. Clin Dermatol. May-Jun 1998;16(3):325-32. [Medline].
Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med. Jul 1985;103(1):49-51. [Medline].
Callen JP, Hughes AP, Kulp-Shorten C. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases. Arch Dermatol. Sep 2001;137(9):1196-8. [Medline].
Allen JE. Drug-induced photosensitivity. Clin Pharm. Aug 1993;12(8):580-7. [Medline].
Gould JW, Mercurio MG, Elmets CA. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol. Oct 1995;33(4):551-73; quiz 574-6. [Medline].
Hrabovsky SL, Elmets CA. Pathogenesis, characteristics, diagnosis, and treatment of pseudoporphyria. Curr Opin in Dermatol. 1996;3:105-10.
| Class | Medication | Phototoxic Reaction | Photoallergic Reaction | Lichenoid Reaction | Pseudoporphyria | Subacute Cutaneous Lupus Erythematosus |
| Antibiotics | Tetracyclines (doxycycline, tetracycline) | Yes | No | Yes | Yes | No |
| Fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin)[1] | Yes | No | No | No | No | |
| Sulfonamides | Yes | No | No | No | No | |
| Nonsteroidal anti-inflammatory drugs[2] | Ibuprofen | Yes | No | Yes | No | No |
| Ketoprofen | Yes | Yes | No | No | No | |
| Naproxen[3] | Yes | No | Yes | Yes | No | |
| Celecoxib[4] | No | Yes | No | Yes | No | |
| Diuretics | Furosemide | Yes | No | No | Yes | No |
| Bumetanide | No | No | No | Yes | No | |
| Hydrochlorothiazide | Yes | No | No | No | Yes | |
| Retinoid | Isotretinoin | Yes | No | No | No | No |
| Acitretin | Yes | No | No | No | No | |
| Hypoglycemics | Sulfonylureas (glipizide, glyburide)[1] | No | Yes | Yes | Yes | No |
| HMG-CoA* reductase inhibitors | Statins (atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin)[5] | Yes | Yes | Yes | Yes | No |
| Epidermal growth factor receptor inhibitors | Cetuximab, panitumumab, erlotinib, gefitinib, lapatinib, vandetanib[6] | Yes | Yes | Yes | Yes | No |
| Photodynamic therapy prophotosensitizers | 5-Aminolevulinic acid[7] | Yes | No | No | No | No |
| Methyl-5-aminolevulinic acid | Yes | No | No | No | No | |
| Verteporfin[8] | Yes | No | No | No | No | |
| Photofrin[9] | Yes | No | No | No | No | |
| Neuroleptic drugs[10] | Phenothiazines (chlorpromazine, fluphenazine, perazine, perphenazine, thioridazine)[11] | Yes | Yes | Yes | No | No |
| Thioxanthenes (chlorprothixene, thiothixene) | Yes | No | No | No | No | |
| Antifungals | Terbinafine | No | No | No | No | Yes |
| Itraconazole | Yes | Yes | No | No | No | |
| Voriconazole[12, 13, 14, 15] | Yes | No | No | Yes | No | |
| Griseofulvin | Yes | Yes | No | No | Yes | |
| Other drugs | Para-aminobenzoic acid | Yes | Yes | No | No | No |
| 5-Fluorouracil | Yes | Yes | Yes | Yes | No | |
| Paclitaxel[2, 16] | Yes | No | No | No | Yes | |
| Amiodarone | Yes | No | No | Yes | No | |
| Diltiazem | Yes | No | No | No | Yes | |
| Quinidine | Yes | Yes | Yes | No | No | |
| Hydroxychloroquine | No | No | Yes | No | No | |
| Coal tar | Yes | No | No | No | No | |
| Enalapril | No | No | No | No | Yes | |
| Dapsone | No | Yes | Yes | Yes | No | |
| Oral contraceptives[17, 18] | No | Yes | No | Yes | No | |
| Sunscreens[19] | Para-aminobenzoic acid | No | Yes | No | No | No |
| Cinnamates | No | Yes | No | No | No | |
| Benzophenones | No | Yes | No | No | No | |
| Salicylates | No | Yes | No | No | No | |
| Fragrances | Musk ambrette | No | Yes | No | No | No |
| 6-Methylcoumarin | No | Yes | No | No | No | |
| *3-Hydroxy-3-methylglutaryl coenzyme A. | ||||||
| Feature | Phototoxic Reaction | Photoallergic Reaction |
| Incidence | High | Low |
| Amount of agent required for photosensitivity | Large | Small |
| Onset of reaction after exposure to agent and light | Minutes to hours | 24-72 hours |
| More than one exposure to agent required | No | Yes |
| Distribution | Sun-exposed skin only | Sun-exposed skin, may spread to unexposed areas |
| Clinical characteristics | Exaggerated sunburn | Dermatitis |
| Immunologically mediated | No | Yes; Type IV |

